Key Points - PR Dated February 4, 2020:
$SKDI is an emerging player in the CBD marketplace.
Acquisition of Products Group, Inc (“Hakuna” or “Hakuna Supply”) - a premier revenue-generating CBD-based products company located in California - closing February 5, 2020.
Hakuna already has over 110 established retail distribution partners across over 20 states in the domestic US market.
$SKDI already capitalized with the right partner.
$SKDI already has the right structure in place to make the acquisition a success for the company and shareholders.
Hakuna is a well-established market leader in CBD-based products with a
broad and relevant distribution footprint already in place.
The acquisition of Products Group, Inc will be via a definitive stock purchase agreement by $SKDI.
Hakuna already has a solid foundation to drive forward revenue - with the resources of $SKDI it will be able to expedite the business plan and expand the brand across both the US and internationally throughout 2020 and beyond.
There will be continual updates over the coming weeks and months about products and the sales and marketing efforts.
Hakuna Supply received the DOPE Magazine Best New Product award for Southern California in the non-cannabis/non-tech category in 2017.
Hakuna has established high-end CBD-based product including:
- CBD Hemp Roast Coffees.
- CBD Coffee Bundles.
- CBD Tea Bundles.
- CBD Drink Drops.
- CBD Gummies.
- CBD Flower.
- Range of premium CBD Teas.
- Other premium products.
Research firm MRFR sees the global CBD market growing at better than 125% annually through 2026.
Brightfield Group sees 2019 alone will show over 900% expansion in total sales of CBD-based products across all related product groups.
$SKDI is pursuing meaningful acquisitions as part of an aggressive M&A strategy designed to position itself as a dominant player in a well-defined, high-growth niche within the rapidly expanding CBD sector.
$SKDI is an emerging player in the CBD marketplace.
Acquisition of Products Group, Inc (“Hakuna” or “Hakuna Supply”) - a premier revenue-generating CBD-based products company located in California - closing February 5, 2020.
Hakuna already has over 110 established retail distribution partners across over 20 states in the domestic US market.
$SKDI already capitalized with the right partner.
$SKDI already has the right structure in place to make the acquisition a success for the company and shareholders.
Hakuna is a well-established market leader in CBD-based products with a
broad and relevant distribution footprint already in place.
The acquisition of Products Group, Inc will be via a definitive stock purchase agreement by $SKDI.
Hakuna already has a solid foundation to drive forward revenue - with the resources of $SKDI it will be able to expedite the business plan and expand the brand across both the US and internationally throughout 2020 and beyond.
There will be continual updates over the coming weeks and months about products and the sales and marketing efforts.
Hakuna Supply received the DOPE Magazine Best New Product award for Southern California in the non-cannabis/non-tech category in 2017.
Hakuna has established high-end CBD-based product including:
- CBD Hemp Roast Coffees.
- CBD Coffee Bundles.
- CBD Tea Bundles.
- CBD Drink Drops.
- CBD Gummies.
- CBD Flower.
- Range of premium CBD Teas.
- Other premium products.
Research firm MRFR sees the global CBD market growing at better than 125% annually through 2026.
Brightfield Group sees 2019 alone will show over 900% expansion in total sales of CBD-based products across all related product groups.
$SKDI is pursuing meaningful acquisitions as part of an aggressive M&A strategy designed to position itself as a dominant player in a well-defined, high-growth niche within the rapidly expanding CBD sector.
1
SFLMaven, Inc. (SFLM) Stock Research Links
"Per Ardua Ad Astra" - "Through Adversity To The Stars"
A very apposite motto for those who trade successfully in the OTC market..
All posts are my opinion - trade at your own risk.
A very apposite motto for those who trade successfully in the OTC market..
All posts are my opinion - trade at your own risk.
